<scp>PFKFB4</scp> facilitates palbociclib resistance in oestrogen receptor‐positive breast cancer by enhancing stemness-Reference-Cited by-同舟云学术

PFKFB4 facilitates palbociclib resistance in oestrogen receptor‐positive breast cancer by enhancing stemness

Published:2022-09-20 Issue:1 Volume:56 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Wang Sijie¹²,Bei Yuncheng²,Tian Qiang²,He Jian³,Wang Rui²,Wang Qiuping²,Sun Luchen¹,Ke Jiangqiong⁴,Xie Congying¹,Shen Pingping¹²^ORCID

Affiliation:

1. Department of Radiation and Medical Oncology The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China

2. State Key Laboratory of Pharmaceutical Biotechnology and The Comprehensive Cancer Center Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, School of Life Sciences, Nanjing University Nanjing China

3. Department of Nuclear Medicine Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School Nanjing China

4. Department of Geriatric Medicine The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China

Funder

National Key Research and Development Program of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13337

Reference57 articles.

1. Cancer Statistics, 2021